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The computational fluid dynamics method, which provides an estimation of the pressure drop in the airway before
and after the stent implantation, is proposed in this study. This method is based on the finite volume model. The
pressure field was solved by the Navier-Stokes equations. The proposed methodology was evaluated in seven
health people (control group) and in fourteen patients who were assigned in two groups, in which one was
tracheal stenosis and the other was bronchial stenosis. The results showed that the pressure drop after tracheal
stent implantation became significantly smaller. For bronchial stent implantation cases, the airway resistance
improved insignificantly.Introduction
Airway tumors related to central airway compression
produces dyspnea, stridor, hemorrhage, obstructive
pneumonia, or combinative syndromes. These patients
branded with a poor prognosis may not benefit from
surgery with a curative intent; however, they will require
procedures for palliation with the hopes of being pro-
vided with an improved quality of life. In 1915, Brunings
and Albrecht [1] raised the model of endoscopic tracheal
stent placement for the therapy of airway strictures. As
the development of material technology, the commercial
silicon stent which could use rigid bronchoscopy to
place the implants was proposed by Duman [2]. From
that time, metallic airway stent insertion can achieve
symptomatic relief in the majority of patients with air-
way obstruction, and mounting researches aimed at
evaluating the effectiveness of metallic airway stents
implants based on the change in lung function [3-8],
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reproduction in any medium, provided the orand survival rate [15-22], have been reported. However,
it was difficult to examine or evaluate the efficacy in
some patients with severe airway obstruction [23,24].
Computer tomography (CT) with two-dimensional
(2D) or three-dimensional (3D) reconstruction image
study can help to evaluate the improvement of the
anatomic structure. However, the real alteration of air-
flow and the spread of gas particles in central airway
before and after airway stents placement could not be
accurately accessed before the Computational Fluid Dy-
namics (CFD) software was applied to mimic the in-
ternal luminal 3D airflow alteration [16], and to imitate
normal human airway internal alterations [25,26]. Xu
and Liu [18,21] reported the change in airway flow and
pressure during airway obstruction. Kabilan [22] also
used the CFD software to record and analyze the sheep
airway flow. In 2005, Chen [23] combined 3D com-
puter tomography and CFD software to investigate the
coronary artery disease after stent placement. However,
there was no report for the airway assessment after
stent placement. Thus, the purpose of this study was
to set up and evaluate a novel model which is capable
of investigating the real airflow dynamic change in cen-
tral airway obstruction after airway stent implant via
combination of CFD technology and 3D computer
tomography to mimic numerical simulation of airflow
alteration.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Subjects
Our research was reviewed and approved by the Institu-
tional Review Board (IRB) at our institution. Subjects
were all recruited at the China Medical University Hos-
pital in Taiwan who underwent tracheobronchial stents
(Ultraflex metallic stents, Boston Scientific, Natick, MA)
placement in the airway. Twenty-one participants were
classified into three groups and diagnostic data were
listed in Table 1. The first group was healthy subjects
from regular health examination without airway obstruc-
tion. The second group was primary or metastatic lung
tumor with tracheal obstruction; and the third group
was primary or metastatic lung tumor with bronchial
obstruction. The recorded clinical data included each
patient’s age, gender, clinical symptoms, and the size and
location of the stent placement.Computed Tomography (CT) images and follow-up
The computed tomographic images of the studied sub-
jects were acquired by the GE Medical Systems, Light
Speed or by the GE Medical Systems, Bright Speed. The
matrix size was 512× 512, the field of view (FOV) was
360-370 mm. The corresponding volxel size was around
0.7 mm ×0.7 mm × 1.25 mm. The slices of CT images
were from 198 to 325. The follow-up time interval for
most of the patients receiving stent implantations was
about 6 months. In some patients receiving bronchial
stent implantation, however, the follow-up time period
could be up to 12 months.Tracheobronchial stent placement and image software
The tracheal or bronchial stents were placed by flexible
bronchoscope (BF-1T260; Olympus; Tokyo, Japan) from









Stent size 20 mm × 4 cm
18 mm × 6 cm
16 mm × 6 cm
16 mm × 4 cm
14 mm × 3 cm
12 mm × 4 cmeach patient received intravenous sedation (midazolam 5
mg) and local anesthetic (2% xylocaine). After evaluation
of the chest computed tomography (CT) images, an
Ultraflex SEMS (Boston Scientific, Natick, MA, USA)
guide wire was inserted from the proximal to distal site
of obstruction in the tracheobronchial airway by a chest
medicine doctor. The doctor determined the size of the
stent and the location of the stent placement by taking
into account of the type, length, and location of the air-
way stenosis. The overall process of stent setting up was
shown in Figure 1. In case that the stent must be moved,
biopsy pliers (FB-15C-1; Olympus, Tokyo, Japan) were
used to grip the end of the stent and to withdraw the
bronchoscopy.Computational Fluid Dynamics (CFD) modeling
In order to simulate the airflow in the airway, the CFD
technique was used for modeling. In this study, we used
the three software packages to reconstruct the 3D airway
anatomy geometry, to generate the volume mesh, and to
calculate the pressure drop before and after the stent im-
plantation, as shown in Figure 2. Furthermore, the
Navier-Stokes equations for the evolution of the airflow
in the airway were employed.
First, the segmented images from the original CT
(Digital Imaging and Communications in Medicine)
DICOM images were processed by the Amira software
package. The three-dimensional airway surface reconstruc-
tion was created with exclusion of the tracheal cartilage.
Second, the volume mesh was generated by the ANSYS
CFD ICEM 11.0. Third, the velocity/pressure field in the
airway was solved by the CFD-ACE software package.
Constant air pressure was imposed at the outlet when
the constant flow rate was applied at the inlet. The wall
of the airway was assumed as the no-slip boundarytenosis Tracheal stenosis Bronchial stenosis
4 6
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Figure 1 The implantation process of the Ultraflex stent. (A) Stent bound onto introducer. (B) Released standard and covered stents.
(C) Releasing stent at bronchoscopy. (D) Fully released stent.
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of air was set to 1.864.10-5 kg m-1s-1 in numerical simula-
tion. According to the airflow rate of van Ertbruggen et
al. [17], the airflow rate of the inlet was set at 100 ml s-1
and the constant pressure of the outlet was applied to 0
Pa in this study. The boundary conditions of the CFD
model were shown in Figure 3. With the length from
about 10 cm above the carina, the viscous pressure drop
in the 10-cm segment of the airway was used for evaluat-
ing the airflow resistance for a respiration process.
Results
First, we tested the CFD model in 7 healthy subjects
(i.e., without airway stenosis). We analyzed the changes
of the cross-sectional area of the inlet and outlet and
pressure drop in the airway for these 7 subjects (the
inlet flow rate was set to 100 ml s-1 and the outlet
pressure was set to 0 Pa) (Table 2). In these cases, the
Reynolds number (Re) was 492± 101 (range: 382~ 677).Figure 2 Procedures of numerical simulation.The mean pressure drop of the inlet was 0.70± 0.41 Pa.
The average airflow rates of the right primary and left
bronchus were 1.06± 0.66 ml s−1 and 0.81± 0.63 ml s−1,
respectively. In addition, the ratio of the inflow air to
the right lobe and left lobe were 56.57% and 43.43%,
respectively.
The changes of the cross-sectional area and pressure
drop before and after the tracheal stent implantations
were listed in Table 3. The average values of the cross-
sectional area before and after stenting implantations
were 1.45 ± 0.51 cm and 1.47 ± 0.86 cm, respectively. The
average pressure drops before and after stenting place-
ment were 10.61 ± 9.22 Pa and 1.71 ± 1.31 Pa. Before the
tracheal stent placement, the average airflow percentages
of the right primary bronchus and the left primary bron-
chus were 48.43% and 51.57%. In contrast, after tracheal
stenting, the average flow percentages of the right pri-
mary and left primary bronchi were 57.71% and 42.29%,
respectively. The percentages of 57.71% and 42.29% were
Figure 3 Boundary conditions were used in numerical simulations. The constant flow rate of the inlet was set at 100 ml s−1. The constant
pressures of the three outlets were applied to 0 Pa. (A) without stenosis; (B) tracheal stenosis; (C) bronchial stenosis for the right primary
bronchus with nearly total collapse; (D) bronchial stenosis for the left primary bronchus with nearly total collapse.
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other words, the fraction of the airway flow of the right
primary bronchus and the left primary bronchus is simi-
lar to the healthy human condition after the tracheal
stent implantation.
For 7 patients with bronchial stent placements, the
values of the cross-sectional areas of the inlet before andTable 2 Cross-sectional areas and pressure drops for 7 health






1 3.06 2.21 1.65 0.99
2 2.05 1.68 1.34 0.67
3 3.45 1.93 1.65 0.55
4 3.14 0.87 1.37 1.88
5 1.33 1.57 1.16 0.83
6 2.12 2.02 1.35 0.53
7 4.17 2.78 2.70 0.99
Average 2.76 1.87 1.60 0.92after stenting were 2.81 ± 0.33 cm and 2.63 ± 0.24 cm re-
spectively. There is a small difference of the area be-
tween before and after bronchial stenting implantations.
The average pressure drop before bronchial stent place-
ment was 0.97 ± 0.55 Pa. After bronchial stent place-
ment, the average pressure drop was 1.24 ± 0.97 Pa after
placement. When comparing the 7 healthy subjects andy subjects
Pressure drop (Pa)




1.28 1.46 0.59 0.15 0.15
0.90 1.42 0.66 0.29 0.29
1.00 1.04 0.63 0.28 0.29
2.08 2.30 0.34 0.07 0.07
0.51 1.19 1.49 0.51 0.49
0.82 1.02 0.91 0.44 0.47
1.35 2.10 0.26 0.10 0.10
1.13 1.50 0.70 0.26 0.27
Table 3 Cross-sectional areas and pressure drops for 7subjects with tracheal stenosis before and after tracheal stent
implantations









1 Before 0.90 1.98 2.54 0.42 0.45 1.31 26.66 0.61 0.52
After 0.53 1.22 0.81 0.53 0.46 1.35 3.96 0.39 0.32
2 Before 1.58 1.61 1.28 1.08 1.64 1.31 4.85 −0.04 −0.01
After 2.24 1.79 1.48 0.99 1.79 1.71 0.59 0.07 0.07
3 Before 1.69 1.37 0.97 0.33 0.78 0.76 6.46 0.26 0.59
After 2.66 1.71 1.62 0.42 1.49 1.33 1.44 0.40 0.39
4 Before 1.98 1.01 0.93 0.21 0.44 1.79 4.73 0.11 0.59
After 1.96 1.00 1.17 0.66 2.04 2.35 0.84 0.14 0.24
5 Before 0.73 1.97 0.90 1.03 0.70 1.45 8.92 0.23 0.02
After 1.02 1.75 1.12 0.97 1.47 1.38 0.68 0.39 0.45
6 Before 1.25 1.42 1.76 0.86 0.81 1.33 2.25 0.27 0.33
After 0.39 1.73 1.54 0.95 0.46 1.52 1.65 0.18 0.23
7 Before 2.07 1.40 1.44 0.37 0.62 0.98 20.36 −0.20 0.41
After 1.53 1.16 1.43 0.43 1.40 1.12 3.15 0.27 0.20
Average Before 1.45 1.53 1.40 0.61 0.77 1.27 10.60 0.17 0.35
After 1.47 1.48 1.31 0.70 1.30 1.53 1.75 0.26 0.27
*: The airflow rate of the inlet was set to 100 ml s-1.
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sure drop for the patients before bronchial stent im-
plantation was greater than that of the healthy people
0.70 Pa v.s. 1.24 Pa. On the other hand, the airway resist-
ance was higher in patients with bronchial stenosis even
after bronchial stent implementations.
In the clinical measurements, we did pulmonary func-
tion test (PFT), including FEV1, PEF (i.e., peak expira-
tory flow reading, which is lower when the airway is
constricted), FEV1%, and FEV1/FVC ratio (i.e., Tiffeneau
index, which is used in the diagnosis of obstructive and
restrictive lung disease) for some patients with stent pla-
cements. The results of two patients correlated with the
results of numerical analysis of airflow alteration were
given here. For the tracheal stenosis (subject #3 in
Table 3), for example, the 80-year-old male patient was
diagnosed with the lung cancer of the left upper lobe
with the lower third tracheal invasion and stridor symp-
tom and the size of the airway stent was 40 mm by 16
mm. Before the tracheal stent placement, the FEV1/FVC
ratio, FEV1, FEV1%, and PEF for subject # 3 were
40.65%, 0.74 L, 37%, and 15.9%, respectively. The FEV1/
FVC ratio of the patient was less than 70% and the pa-
tient was usually diagnosed as the chronic obstructive
pulmonary disease (COPD). The air trapping (i.e., gas
trapping, which is an abnormal retention of air in the
lungs where it is difficult to exhale completely.) was also
observed in this patient. The value of the PEF reading
for subject #3 was significantly less than 50%. Thus, thepatient has a severe airway narrowing. After the two
days of the stent placement, the FEV1/FVC, FEV1, and
FEV1% were 69.79%, 1.75 L, and 87.1%, respectively.
The stridor symptom of the patient was significantly
improved. In CFD simulations, we also found that the
pressure drops were 6.46 and 1.44 Pa before and after
the stent placement, respectively. In other words, the
airway resistance was significantly reduced after the
stent placement.
For the bronchus stenosis with the stent placement
(subject #2 in Table 4), for instance, the 69-year-old fe-
male patient was diagnosed with the breast cancer with
the right main bronchus metastasis. The patient was
treated by the right primary bronchial stent placement
and the stent size was 30 mm by 14 mm. The measure-
ment values of the FEV1/FVC ratio, FEV1, and FEV1%
of the patient were 53.5%, 0.92 L, and 59.6%, respect-
ively. After the bronchial stent implantation, the meas-
urement values of the FEV1/FVC ratio, FEV1, FEV1%,
and PEF became 74.6%, 1.83 L, 118.2%, and 63%, re-
spectively. The FEV1 value of the patient was changed
from 0.92 L to 1.83 L. From CFD simulations, the pres-
sure drops of the right primary bronchus were 0.31 and
0.07 Pa before and after the right bronchial stent place-
ment, respectively. At the meantime, the pressure drop
of the left primary bronchus varied from 0.19 Pa to 0.09
Pa after the right primary bronchus. Therefore, the CFD
numerical results are consistent with the clinical mea-
surements. The comparison of CFD simulation results
Table 4 Cross-sectional areas and pressure drops for 7subjects with bronchus stenosis before and after bronchial stent
implantations









1 Before 2.94 2.72 1.48 1.06 1.89 0 0.65 0.28 0.40
After 2.40 2.44 2.20 0.96 1.92 0.89 0.35 0.17 0.23
2 Before 2.77 0.23 1.62 0.97 1.06 1.82 1.05 0.31 0.19
After 3.00 0.64 1.31 0.84 0.91 1.73 1.17 0.07 0.09
3 Before 3.38 2.50 2.46 0.79 1.00 1.11 0.50 0.33 0.39
After 2.89 2.83 1.91 0.98 0.96 0.69 0.50 0.34 0.38
4 Before 2.17 0.75 1.85 0 0 1.59 2.12 2.05 1.82
After 2.44 0.76 1.67 0.07 0.45 1.66 1.74 1.57 1.45
5 Before 2.80 1.59 2.00 0 0.84 1.60 0.89 0.57 0.47
After 2.58 1.03 0.99 0 0.45 1.25 3.36 2.44 2.79
6 Before 2.65 1.75 1.59 0.48 0.71 2.02 0.54 0.44 0.30
After 2.34 1.56 1.27 0.44 0.44 1.77 0.83 0.64 0.41
7 Before 2.95 1.80 1.97 0.42 1.14 0 1.05 0.62 0.82
After 2.80 1.66 1.27 0.36 1.40 1.21 0.62 0.29 0.38
Average Before 2.84 1.62 1.85 0.53 0.94 1.16 0.97 0.65 0.62
After 2.63 1.56 1.51 0.52 0.93 1.31 1.24 0.78 0.81
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placement was shown in Table 5 (in the last page of the
manuscript).
Discussion
This study used computational fluid dynamics method,
based on the finite volume model, to study the pressure
change of the tracheobronchial tree before and after the
stent placement. After tracheal stent implantations, the
ratio between the right lung and the left was 57.71% to
42.29%, which was similar in healthy people. The ratio
of airflow in the right lung and the left lung is 56:44 in
normal people [17,27]. We found that the tracheal stent
placement can enlarge the lumen of the trachea to im-
prove airway symptom. The pressure drop was signifi-
cantly decreased after the stenting implantation. SmallerTable 5 Comparison of CFD simulation results and pulmonary
stent placement
Diagnosis Sex Age Stent
*Tracheal stenosis Lung cancer Male 80 40 mm ×16 mm
**Bronchial stenosis Breast cancer Female 69 30 mm ×14 mm
*Tracheal stenosis: subject #3 in Table 3.
**Bronchial stenosis: subject #2 in Table 4.pressure drop has a smaller airway resistance. Vergnon
[3] found that the peak expiratory flow rate was
decreased when the airflow resistance was increased in
patients with central airway obstruction. In our study,
all the clinical respiratory distress symptoms of the
patients treated by airway stent implantation had been
improved.
Furthermore, we also found that the airflow in the air-
way was significantly improved after the tracheal stent
implantation for the patient with the tumor-related cen-
tral airway obstruction. In those patients with airway
tumors that compressed the tracheas, the luminal cross-
sectional area of the trachea became smaller and the air-
way resistance was increased. Although the airway stent
placement cannot significantly enlarge the narrowed lu-











Before 0.74 37 40.65 6.46 1.69
After 1.75 87.1 69.79 1.44 2.66
Before 0.92 59.6 53.5 1.05 2.77
After 1.83 118.2 74.6 1.17 3.00
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that of healthy people. For the tracheal stent implant-
ation cases, the average flow of the right and left main
bronchus are 57.71% and 42.29%, respectively. In other
words, the airflow ratio of the right lung and the left
lung of the patients with the tracheal stent implantations
was similar to those of the healthy people without tra-
cheal stenosis (i.e., 56.58% and 43.42%).
For the bronchial stent implantation cases, the pressure
drop of the airway changed insignificantly. Miyazawa
[28] also demonstrated the same situation because the
bronchus still collapsed in obstructive lung disease even
with the bronchial stenting. In addition, in these cases
the turbulent airflow decreased, but did not reach the
normal respiratory conditions.
In this study all the 14 patients were originally
arranged to have the pulmonary function tests but not
all of them can be completed for the study due to the
general poor condition and dyspnea of the patients.
Eventually only eight patients had pre-stent PFTs, five
had post-stent PFTs, and four had both pre- and post-
stent PFTs for comparison. From the two examples
shown in Table 5, it was noted that the CFD numerical
results are consistent with the clinical measurements.
There are some limitations of this pilot study. First, the
case number is small and larger numbers are urgently
needed for further evaluation. Second, the limited cases
are of different tumor types and cancer stages so that the
temporarily analyzing classification may not be so conclu-
sive. Third, the lack uniform following up time schedule
in this retrospective study, such as the time of computed
tomography, may also cause some errors in the analysis.
Conclusion
In conclusion, we provide a comprehensive model to
systematically evaluate patients with obstructive lung
tumor. From the limited examples we have found that
CFD numerical results correlated well with the results of
PFTs, indicating that CFD can potentially become a clin-
ical prognosis prediction tool to assess lung cancer
patients who have poor general condition and PFTs can-
not be successfully applied to. Also, we found that tra-
cheobronchial stent placement indeed improve cancer
patients’ quality of life by lowering the resistance in their
respiratory tract. The model is very helpful in not only
evaluating the outcome of personalized stent placement
but following up of each patient undergoes tracheal and/
or bronchial stent placement.
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